LACOSAMIDE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68462-697 -
Package NDC
68462-697-30 -
Application number
ANDA220268 -
SPL ID
bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc -
SPL set ID
bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc -
UNII
563KS2PQY5 -
RxCUI
809974
What the source publishes
- Labeler
- GLENMARK PHARMACEUTICALS INC., USA
- Active ingredients
- LACOSAMIDE
- Form
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "LACOSAMIDE",
"splId": "bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc",
"labels": [
{
"setId": "bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "GLENMARK PHARMACEUTICALS INC., USA",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 VIAL in 1 CARTON (68462-697-30) / 20 mL in 1 VIAL (68462-697-20)",
"package_ndc": "68462-697-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20260316"
}
],
"productId": "68462-697_bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "68462-697",
"deaSchedule": "CV",
"genericName": "LACOSAMIDE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LACOSAMIDE",
"strength": "10 mg/mL"
}
],
"applicationNumber": "ANDA220268",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260316",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486"
],
"upc": [
"0368462697207"
],
"unii": [
"563KS2PQY5"
],
"rxcui": [
"809974"
],
"spl_set_id": [
"bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"manufacturer_name": [
"GLENMARK PHARMACEUTICALS INC., USA"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68462-697_bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc"